You are invited! DEADLINE FRIDAY 6 FEBRUARY 2026 As a board- certified dermatologist practicing in an African country, you are invited to participate in a modified e-Delphi consensus process to support the development of the African Clinical Practice Guidelines for the Diagnosis and Management of Atopic Dermatitis (Eczema), led by the African Society of Dermatology […]
Read More
What JACI’s 2025 Review Tells Us In 2024, following the fourth Global Allergy Forum in Davos, the journal Allergy published the 4th Davos Declaration, identifying atopic dermatitis (AD) as the prototype of epithelial barrier–driven chronic inflammatory diseases and a gateway to other allergic conditions (DOI: 10.1111/all.16247). In 2025, the Journal of Allergy and Clinical Immunology […]
Read More
AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
Are you under 30 and ready to prove your expertise in Atopic Dermatitis? The RAJKA-ISAD Symposium is calling all residents, fellows, and early-career practitioners (ECP) to step out of the clinic and into the arena. We are launching “The AD Masterminds”—a high-stakes, high-energy team tournament designed to crown the future leaders of AD care. 🧩 […]
Read More
Aligning Measurement with Patient Experience At the ISAD–WHO closed workshop held in Melbourne in October 2025, international experts and patient representatives explored how a Treat-to-Target (T2T) strategy could be meaningfully adapted to atopic dermatitis (AD). The meeting brought together dermatologists, pediatric dermatologists, allergists, rheumatologists, pulmonologists, pharmacists, global health experts, and patient advocates from Europe, Asia, […]
Read MoreMotto: Science and Empathy in Atopic Dermatitis 17-19 October 2026, Beijing, China + New in 2026 for Early-Career Pros: All you need to know about AD Dear ISADers, We are proud and excited to welcome you in Beijing, China, to the 16th Georg RAJKA International Symposium on Atopic Dermatitis (ISAD), in 2026. Its motto “Science […]
Read More
One Th2 Response, Two Outcomes: Itch Versus Inflammation?➜ DOI: 10.1111/exd.70171This research letter suggests that pruritus and inflammation may be driven by partially distinct Th2 programs. In mouse models of dermatitis, IL-31 is mainly produced by a specific subset of T cells, whereas IL-5 and IL-13 are largely derived from ILC2s. This cellular dissociation offers a plausible [...] Read More
Dear colleagues, I remind you that you can yourself submit or encourage your younger colleagues who have already a career track oriented around Atopic Dermatitis to apply to the 2026 Rajka’s Medal kindly donated by Mrs Susanne RAJKA, PhD (Oslo). The deadline is July 1st, 2026. The 2026 Rajka Medal and 15.000 EUR Prize will […]
Read More
Aligning Measurement with Patient Experience At the ISAD–WHO closed workshop held in Melbourne in October 2025, international experts and patient representatives explored how a Treat-to-Target (T2T) strategy could be meaningfully adapted to atopic dermatitis (AD). The meeting brought together dermatologists, pediatric dermatologists, allergists, rheumatologists, pulmonologists, pharmacists, global health experts, and patient advocates from Europe, Asia, […]
Read More
In atopic dermatitis (AD) — a condition already saturated with poor quality studies on anxiety, depression, and socioeconomic burden — sexual health rarely appears on the radar of clinicians, researchers, or guideline developers. The new study by Sánchez et al. from Colombia breaks this silence, reminding us of an overlooked but profoundly human dimension of […]
Read More